New preclinical data from Arnatar’s ACT-UP1 platform will be presented at @asnkidney.bsky.social’s #KidneyWeek25 (Nov 5–9, Houston) & @aasldnews.bsky.social’s #LiverMeeting25 (Nov 7–11, DC). Exploring novel RNA therapies for #ADPKD, #LiverFibrosis & #ALGS.

🧬 www.arnatar.com/news/arnatar...